tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Anteris Technologies Reports Q3 2025 Progress and Financials
PremiumCompany AnnouncementsAnteris Technologies Reports Q3 2025 Progress and Financials
2M ago
Promising Potential of Anteris Technologies’ DurAVR System Justifies Buy Rating
Premium
Ratings
Promising Potential of Anteris Technologies’ DurAVR System Justifies Buy Rating
2M ago
Anteris Technologies Reports Positive DurAVR® THV Outcomes
Premium
Company Announcements
Anteris Technologies Reports Positive DurAVR® THV Outcomes
2M ago
Promising Investment Opportunity: Anteris Technologies’ DurAVR Platform Showcases Outstanding Clinical Outcomes
PremiumRatingsPromising Investment Opportunity: Anteris Technologies’ DurAVR Platform Showcases Outstanding Clinical Outcomes
3M ago
Anteris Technologies reports clinical outcomes for DurAVR THV in patients
Premium
The Fly
Anteris Technologies reports clinical outcomes for DurAVR THV in patients
3M ago
Anteris Technologies Begins Global PARADIGM Trial Enrollment
Premium
Company Announcements
Anteris Technologies Begins Global PARADIGM Trial Enrollment
3M ago
Anteris Technologies Prepares for Annual Stockholder Meeting
PremiumCompany AnnouncementsAnteris Technologies Prepares for Annual Stockholder Meeting
3M ago
Anteris Technologies Gains European Clearance for Heart Valve Trial
Premium
Company Announcements
Anteris Technologies Gains European Clearance for Heart Valve Trial
3M ago
Anteris receives first European regulatory clearance to commence DurAVR trial
Premium
The Fly
Anteris receives first European regulatory clearance to commence DurAVR trial
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100